Download full-text PDF

Source
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC10639100PMC
http://dx.doi.org/10.1093/ehjcr/ytad535DOI Listing

Publication Analysis

Top Keywords

trans-femoral aortic
4
aortic valve
4
valve implantation
4
implantation unrepaired
4
unrepaired aortic
4
aortic co-arctation
4
trans-femoral
1
valve
1
implantation
1
unrepaired
1

Similar Publications

Background: The management of Transcatheter Aortic Valve Implantation (TAVI) patients with a small aortic annulus (SAA) postures a substantial challenge, increasing the risk of patient- prosthesis mismatch (PPM) and overall mortality.

Aims: This study aimed to compare the hemodynamic and clinical outcomes of transcatheter balloon-expandable valve (BEV) versus transcatheter self-expandable valve (SEV) in SAA.

Methods: We conducted propensity score matching (PSM) of severe AS patients with SAA who underwent trans-femoral TAVR and enrolled to the Israeli TAVR registry between the years 2008 and 2023.

View Article and Find Full Text PDF

Background: Trans-femoral (TF) represents the main access for TAVI. Although there are various technical strategies to conduct TF-TAVI (pacing modality, secondary arterial access, primary access puncture etc.), the optimal technique is not recognized.

View Article and Find Full Text PDF

[Local versus locoregional anesthesia in transfemoral TAVI procedures].

Ann Cardiol Angeiol (Paris)

November 2024

Service de cardiologie, Centre Hospitalo-Universitaire de Reims, 51 avenue Cognacq Jay, 51100 Reims, France. Electronic address:

Introduction: Transcatheter aortic valve implantation (TAVI) has become the treatment of choice for the most fragile patients with severe aortic stenosis. The transfemoral route is preferred as the simplest and safest. The aim of our study was to compare the efficacy, tolerance and safety of local vs.

View Article and Find Full Text PDF
Article Synopsis
  • This meta-analysis investigates the potential advantages of transcarotid (TC-TAVR) access over transfemoral (TF-TAVR) access for patients undergoing transcatheter aortic valve replacement (TAVR).
  • The study reviewed seven adjusted studies from PubMed/MEDLINE and Cochrane Library, involving 6609 patients, with 5048 receiving TF-TAVR and 1561 receiving TC-TAVR.
  • Findings show no significant differences in mortality, major bleeding, or stroke/transient ischemic attack between the two methods, though TC-TAVR had a lower risk of vascular complications, suggesting it could be a feasible alternative to TF-TAVR.
View Article and Find Full Text PDF

A 53-year-old man with inotrope-dependent advanced heart failure was admitted with acute decompensation and underwent urgent listing for heart transplant.

View Article and Find Full Text PDF

Want AI Summaries of new PubMed Abstracts delivered to your In-box?

Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!